Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Nutrients ; 14(13)2022 Jul 04.
Article in English | MEDLINE | ID: mdl-35807941

ABSTRACT

Hypovitaminosis D is a serious public health problem, representing an independent factor in mortality among the general population. Vitamin D deficiency may affect up to one billion people worldwide. Recently, the potential association between vitamin D levels and stroke has gained increasing attention. Many studies suggest that maintaining normal serum vitamin D levels is associated with improvement of the cardiovascular system and a reduction in stroke risk. As a neurosteroid, vitamin D influences brain development and function and immunomodulation and affects brain neuroplasticity. It supports many processes that maintain homeostasis in the body. As stroke is the second most common cause of death worldwide, more studies are needed to confirm the positive effects of vitamin D supplementation, its dosage at different stages of the disease, method of determination, and effect on stroke onset and recovery. Many studies on stroke survivors indicate that serum vitamin D levels only offer insignificant benefits and are not beneficial to recovery. This review article aims to highlight recent publications that have examined the potential of vitamin D supplementation to improve rehabilitation outcomes in stroke survivors. Particular attention has been paid to stroke prevention.


Subject(s)
Stroke Rehabilitation , Stroke , Vitamin D Deficiency , Dietary Supplements , Humans , Stroke/complications , Stroke/prevention & control , Vitamin D , Vitamin D Deficiency/complications , Vitamin D Deficiency/drug therapy , Vitamins/therapeutic use
2.
Cancers (Basel) ; 14(6)2022 Mar 11.
Article in English | MEDLINE | ID: mdl-35326606

ABSTRACT

Many of the anticancer agents that are currently in use demonstrate severe side effects and encounter increasing resistance from the target cancer cells. Thus, despite significant advances in cancer therapy in recent decades, there is still a need to discover and develop new, alternative anticancer agents. The plant kingdom contains a range of phytochemicals that play important roles in the prevention and treatment of many diseases. The Solanaceae family is widely used in the treatment of various diseases, including cancer, due to its bioactive ingredient content. The purpose of this literature review is to highlight the antitumour activity of Solanaceae extracts-single isolated compounds and nanoparticles with extracts-and their synergistic effect with chemotherapeutic agents in various in vitro and in vivo cancer models. In addition, the biological properties of many plants of the Solanaceae family have not yet been investigated, which represents a challenge and an opportunity for future anticancer therapy.

3.
Nutrients ; 14(6)2022 Mar 08.
Article in English | MEDLINE | ID: mdl-35334790

ABSTRACT

Bladder cancer (BC) is the most common tumor of the urinary system in the world. Moreover, despite using anticancer therapies, BC is also characterized by a high recurrence risk. Among numerous risk factors, cigarette smoking, occupational exposure to certain aromatic compounds, and genetic factors contribute most strongly to BC development. However, the epidemiological data to date suggests that diet quality may influence some carcinogenic factors of BC and, therefore, might have a preventative effect. Adequate consumption of selected fruits with scientifically proven properties, including pomegranates and cranberries, can significantly reduce the risk of developing BC, even in those at risk. Therefore, in this article, we aim to elucidate, using available literature, the role of fruits, including pomegranates, cranberries, citrus fruits, cactus pears, and apples, in BC prevention and treatment. Previous data indicate the role of compounds in the above-mentioned fruits in the modulation of the signaling pathways, including cell proliferation, cell growth, cell survival, and cell death.


Subject(s)
Fruit , Urinary Bladder Neoplasms , Diet , Humans , Malus , Risk Factors , Urinary Bladder Neoplasms/etiology , Urinary Bladder Neoplasms/prevention & control
4.
Int J Mol Sci ; 22(19)2021 Oct 02.
Article in English | MEDLINE | ID: mdl-34639048

ABSTRACT

Cognitive function decline is strictly related to age, resulting in the loss of the ability to perform daily behaviors and is a fundamental clinical neurodegeneration symptom. It has been proven that an adequate diet, comprehensive nutrition, and a healthy lifestyle may significantly inhibit neurodegenerative processes, improving cognitive functions. Therefore, intensive research has been conducted on cognitive-enhancing treatment for many years, especially with substances of natural origin. There are several intervention programs aimed at improving cognitive functions in elderly adults. Cognitive functions depend on body weight, food consumed daily, the quality of the intestinal microflora, and the supplements used. The effectiveness in the prevention of dementia is particularly high before the onset of the first symptoms. The impact of diet and nutrition on age-associated cognitive decline is becoming a growing field as a vital factor that may be easily modified, and the effects may be observed on an ongoing basis. The paper presents a review of the latest preclinical and clinical studies on the influence of natural antioxidants on cognitive functions, with particular emphasis on neurodegenerative diseases. Nevertheless, despite the promising research results in animal models, the clinical application of natural compounds will only be possible after solving a few challenges.


Subject(s)
Aging , Antioxidants/therapeutic use , Biological Products/therapeutic use , Cognition Disorders/drug therapy , Cognition Disorders/etiology , Neurodegenerative Diseases/complications , Animals , Antioxidants/pharmacology , Biological Products/pharmacology , Clinical Trials as Topic , Cognition/drug effects , Cognition Disorders/diagnosis , Cognitive Dysfunction/diagnosis , Cognitive Dysfunction/drug therapy , Cognitive Dysfunction/etiology , Dietary Supplements , Drug Evaluation, Preclinical , Humans , Neurodegenerative Diseases/drug therapy , Neurodegenerative Diseases/etiology , Treatment Outcome
5.
Molecules ; 26(20)2021 Oct 14.
Article in English | MEDLINE | ID: mdl-34684788

ABSTRACT

It is known that Senna obtusifolia has been used in medicine since ancient times due to the content of many valuable compounds with a pro-health effect. One of them is betulinic acid, which is a pentacyclic triterpene with antimalarial, antiviral, anti-inflammatory and anticancer properties. In this work, a continuation of our previous research, an attempt was made to increase the level of betulinic acid accumulation by the cultivation of transgenic hairy roots that overexpress the squalene synthase gene in a 10 L sprinkle bioreactor with methyl jasmonate elicitation. We present that the applied strategy allowed us to increase the content of betulinic acid in hairy root cultures to the level of 48 mg/g dry weight. The obtained plant extracts showed a stronger cytotoxic effect on the U87MG glioblastoma cell line than the roots grown without elicitors. Additionally, the induction of apoptosis, reduction of mitochondrial membrane potential, chromosomal DNA fragmentation and activation of caspase cascades are demonstrated. Moreover, the tested extract showed inhibition of topoisomerase I activity.


Subject(s)
Acetates/pharmacology , Antineoplastic Agents, Phytogenic/metabolism , Cyclopentanes/pharmacology , Oxylipins/pharmacology , Pentacyclic Triterpenes/metabolism , Senna Plant/drug effects , Senna Plant/metabolism , A549 Cells , Antineoplastic Agents, Phytogenic/biosynthesis , Antineoplastic Agents, Phytogenic/pharmacology , Apoptosis/drug effects , Bioreactors , Biotechnology , Cell Line, Tumor , Cell Survival/drug effects , DNA Damage , DNA Fragmentation/drug effects , Humans , Membrane Potential, Mitochondrial/drug effects , Pentacyclic Triterpenes/pharmacology , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Growth Regulators/pharmacology , Plant Roots/drug effects , Plant Roots/growth & development , Plant Roots/metabolism , Plants, Genetically Modified , Plants, Medicinal/drug effects , Plants, Medicinal/growth & development , Plants, Medicinal/metabolism , Senna Plant/growth & development , Betulinic Acid
6.
Nutrients ; 13(8)2021 Aug 05.
Article in English | MEDLINE | ID: mdl-34444864

ABSTRACT

Nutrition and rehabilitation are crucial in post-stroke recovery, especially in the elderly. Since stroke is the leading cause of long-term disability, there is a need to promote special, individually tailored nutrition strategies targeting older patients with low motor ability. Chronic stroke survivors have higher risk of developing nutrition-related chronic diseases, such as sarcopenia, anemia, type 2 diabetes mellitus and osteoporosis. Moreover, reduced motor activity, cognitive impairment and depression might be aggravated by poor malnutrition status. Accumulated data suggest that nutritional supplements and neuroprotective diets can be associated with better effectiveness of post-stroke rehabilitation as well as brain recovery. Therefore, this review focuses on preventive strategies that can improve dietary intake and change dietary patterns. We highlight the importance of neuroprotective diets, the problem of dysphagia and the role of nutrition in rehabilitation. This article focuses on potential nutritional supplements and neuroprotective diets that may have an impact on functional recovery during and after rehabilitation. Moreover, a new approach to post-stroke neuroplasticity including the use of agents from marine sources such as fucoxanthin and tramiprosate as compounds that might be used as potential neuroprotectants with antioxidative and anti-inflammatory properties is introduced.


Subject(s)
Diet/methods , Dietary Supplements , Malnutrition/prevention & control , Nutrition Therapy/methods , Stroke Rehabilitation/methods , Aged , Aged, 80 and over , Anti-Inflammatory Agents/administration & dosage , Antioxidants/administration & dosage , Eating , Female , Humans , Male , Malnutrition/etiology , Neuroprotection , Neuroprotective Agents , Nutritional Status , Recovery of Function , Stroke/complications , Stroke/physiopathology
7.
Int J Mol Sci ; 22(15)2021 Jul 21.
Article in English | MEDLINE | ID: mdl-34360552

ABSTRACT

Bladder cancer (BC) is the second most common genitourinary cancer. In 2018, 550,000 people in the world were diagnosed with BC, and the number of new cases continues to rise. BC is also characterized by high recurrence risk, despite therapies. Although in the last few years, the range of BC therapy has considerably widened, it is associated with severe side effects and the development of drug resistance, which is hampering treatment success. Thus, patients are increasingly choosing products of natural origin as an alternative or complementary therapeutic options. Therefore, in this article, we aim to elucidate, using the available literature, the role of natural substances such as curcumin, sulforaphane, resveratrol, quercetin, 6-gingerol, delphinidin, epigallocatechin-3-gallate and gossypol in the BC treatment. Numerous clinical and preclinical studies point to their role in the modulation of the signaling pathways, such as cell proliferation, cell survival, apoptosis and cell death.


Subject(s)
Antineoplastic Agents/therapeutic use , Biological Products/therapeutic use , Urinary Bladder Neoplasms/drug therapy , Animals , Humans
8.
Int J Mol Sci ; 22(15)2021 Jul 23.
Article in English | MEDLINE | ID: mdl-34360658

ABSTRACT

Malnutrition is a serious problem in post-stroke patients. Importantly, it intensifies with hospitalization, and is related to both somatic and psychological reasons, as well as is associated with the insufficient knowledge of people who accompany the patient. Malnutrition is a negative prognostic factor, leading to a reduction in the quality of life. Moreover, this condition significantly extends hospitalization time, increases the frequency of treatment in intensive care units, and negatively affects the effectiveness of rehabilitation. Obtaining growing data on the therapeutic effectiveness of new compounds of natural origin is possible through the use of pharmacodynamic and analytical methods to assess their therapeutic properties. The proper supply of nutrients, as well as compounds of natural origin, is an important element of post-stroke therapy, due to their strong antioxidant, anti-inflammatory, neuroprotective and neuroplasticity enhancing properties. Taking the above into account, in this review we present the current state of knowledge on the benefits of using selected substances of natural origin in patients after cerebral stroke.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Biological Products/pharmacology , Dietary Supplements , Malnutrition/prevention & control , Neuroprotection , Stroke/drug therapy , Animals , Humans
9.
J Rehabil Med ; 51(11): 854-860, 2019 Dec 16.
Article in English | MEDLINE | ID: mdl-31690951

ABSTRACT

BACKGROUND: Activation of immunologically competent cells results in the overproduction of pro-inflammatory factors, and causes progression of nerve tissue damage. However, the potential neuroprotective effects of these factors in brain damage have not been well investigated. OBJECTIVE: To evaluate the effect of extremely low frequency electromagnetic field (ELF-EMF) treatment on the molecular mechanism of inflammatory cytokine activity in post-stroke patients. METHODS: All patients underwent the same rehabilitation program, but the ELF-EMF group were also given ELF-EMF treatment. Both groups have been used in our previous studies. In order to determine the plasma level of cytokines, the levels of interleukin 1ß (IL-1ß), interleukin 2 (IL-2), interferon-γ (INF-γ) and transforming growth factor ß (TGF-ß) were evaluated, and the level of IL-1ß mRNA expression was determined. RESULTS: After ELF-EMF treatment, both IL-1ß plasma level and IL-1ß mRNA expression level, as well as IL-2 plasma level increased, while IFN-γ and TGF-ß levels did not change. CONCLUSION: The increased expression of IL-1ß found in this study may be a response to ELF-EMF stimulation. It is hypothesized that a neuroprotective role of this cytokine may occur due to IL-1ß-dependent regulation of neurotrophic factors. Further research is needed to explore this hypothesis.


Subject(s)
Cytokines/metabolism , Inflammation/genetics , Magnetic Field Therapy/methods , Stroke/therapy , Adult , Female , Humans , Male , Middle Aged
10.
Nutrients ; 11(7)2019 Jul 05.
Article in English | MEDLINE | ID: mdl-31284389

ABSTRACT

Multiple sclerosis (MS) is a complex disease of the central nervous system (CNS). The etiology of this multifactorial disease has not been clearly defined. Conventional medical treatment of MS has progressed, but is still based on symptomatic treatment. One of the key factors in the pathogenesis of MS is oxidative stress, enhancing inflammation and neurodegeneration. In MS, both reactive oxygen and nitrogen species are formed in the CNS mainly by activated macrophages and microglia structures, which can lead to demyelination and axon disruption. The course of MS is associated with the secretion of many inflammatory and oxidative stress mediators, including cytokines (IL-1b, IL-6, IL-17, TNF-α, INF-γ) and chemokines (MIP-1a, MCP-1, IP10). The early stage of MS (RRMS) lasts about 10 years, and is dominated by inflammatory processes, whereas the chronic stage is associated with neurodegenerative axon and neuron loss. Since oxidative damage has been known to be involved in inflammatory and autoimmune-mediated processes, antioxidant therapy could contribute to the reduction or even prevention of the progression of MS. Further research is needed in order to establish new aims for novel treatment and provide possible benefits to MS patients. The present review examines the roles of oxidative stress and non-pharmacological anti-oxidative therapies in MS.


Subject(s)
Antioxidants/therapeutic use , Central Nervous System/drug effects , Multiple Sclerosis/drug therapy , Oxidative Stress/drug effects , Animals , Anti-Inflammatory Agents/therapeutic use , Antioxidants/adverse effects , Central Nervous System/metabolism , Central Nervous System/physiopathology , Cytokines/metabolism , Diet, Healthy , Humans , Inflammation Mediators/metabolism , Multiple Sclerosis/diet therapy , Multiple Sclerosis/metabolism , Multiple Sclerosis/physiopathology , Nutritional Status , Signal Transduction , Treatment Outcome
11.
Nutrients ; 11(1)2019 Jan 05.
Article in English | MEDLINE | ID: mdl-30621248

ABSTRACT

Because of the side-effects of commonly used anti-platelet and anticoagulant drugs, investigations into plant substances with similar activities are very common. Based on our own studies in recent years, we estimate that it is possible to use natural compounds to both inhibit coagulation pathway enzymes and to reduce blood platelets' activation. As such, in our current study we wanted to verify the anti-platelet and anticoagulant properties of grape seed extract (GSE) using in vitro models. During our analysis, the following parameters were analyzed: Coagulation times, thromboelastometry assays (coagulation time, clot formation time and maximum clot firmness), aggregation of platelets and phosphorylation of vasodilator-stimulated phosphoprotein (VASP). Adenosine diphosphate (ADP)-induced aggregation was lower in GSE 7.5 µg/mL as well as in GSE 15.0 µg/mL. A similar dependence was observed in VASP assays for GSE 7.5 µg/mL and GSE 15 µg/mL. The effect on plasma coagulation tests was distinct only with GSE 15 µg/mL. All of the thromboelastometry variables were statistically significant with 15.0 µg/mL GSE concentration. Our results show, for the first time, the multi-potential effect of grape seed extract on coagulation systems, and clearly suggest that grape seed extract could be considered a promising nutraceutical in the prevention of cardiovascular thrombotic events caused by different mechanisms.


Subject(s)
Anticoagulants/pharmacology , Plant Extracts/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Polyphenols/analysis , Seeds/chemistry , Vitis , Adenosine Diphosphate/pharmacology , Adult , Blood Coagulation/drug effects , Cell Adhesion Molecules/metabolism , Dietary Supplements , Female , Humans , Male , Microfilament Proteins/metabolism , Phosphoproteins/metabolism , Phosphorylation/drug effects , Plant Extracts/chemistry , Platelet Aggregation/drug effects
12.
Scand J Clin Lab Invest ; 78(7-8): 626-631, 2018.
Article in English | MEDLINE | ID: mdl-30755096

ABSTRACT

Oxidative stress plays the most important role in the pathogenesis of stroke. Extremely low frequency electromagnetic field (ELF-EMF) therapy may be complementary in post-stroke therapy, as it modulates oxidative stress. The aim of this study was to evaluate the messenger ribonucleic acid (mRNA) levels of certain antioxidant genes in post-stroke patients given ELF-EMF therapy. Forty-eight post-stroke patients were divided into two groups: an ELF-EMF group and a non-ELF-EMF group. All patients underwent the same program of physical therapy, but the ELF-EMF group was additionally given ELF-EMF treatment. In order to determine the level of gene expression, we evaluated the level of mRNA expression of catalase, superoxide dismutase, and glutathione peroxidase. We observed that after ELF-EMF therapy, the mRNA expression of the studied genes (CAT, SOD1, SOD2, GPx1, and GPx4) significantly increased, which enhanced the antioxidant defence of the body. ELF-EMF therapy intensifies the endogenous antioxidant system by increasing the mRNA expression of genes encoding antioxidant enzymes and enhances the effectiveness of post-stroke patient therapy.


Subject(s)
Antioxidants/metabolism , Magnetic Field Therapy , Stroke/therapy , Adult , Female , Gene Expression , Humans , Male , Middle Aged , RNA, Messenger/metabolism
13.
Nutrients ; 9(12)2017 Dec 14.
Article in English | MEDLINE | ID: mdl-29240674

ABSTRACT

Flavonolignans are the main components of silymarin, which represents 1.5-3% of the dry fruit weight of Milk thistle (Silybum marianum L. Gaernt.). In ancient Greece and Romania, physicians and herbalists used the Silybum marianum to treat a range of liver diseases. Besides their hepatoprotective action, silymarin flavonolignans have many other healthy properties, such as anti-platelet and anti-inflammatory actions. The aim of this study was to evaluate the toxic effect of flavonolignans on blood platelets, peripheral blood mononuclear cells (PBMCs) and human lung cancer cell line-A549-using different molecular techniques. We established that three major flavonolignans: silybin, silychristin and silydianin, in concentrations of up to 100 µM, have neither a cytotoxic nor genotoxic effect on blood platelets, PMBCs and A549. We also saw that silybin and silychristin have a protective effect on cellular mitochondria, observed as a reduction of spontaneous mitochondrial DNA (mtDNA) damage in A549, measured as mtDNA copies, and mtDNA lesions in ND1 and ND5 genes. Additionally, we observed that flavonolignans increase the blood platelets' mitochondrial membrane potential and reduce the generation of reactive oxygen species in blood platelets. Our current findings show for the first time that the three major flavonolignans, silybin, silychristin and silydianin, do not have any cytotoxicity and genotoxicity in various cellular models, and that they actually protect cellular mitochondria. This proves that the antiplatelet and anti-inflammatory effect of these compounds is part of our molecular health mechanisms.


Subject(s)
DNA Damage , DNA, Mitochondrial/chemistry , Flavonolignans/pharmacology , A549 Cells , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Apoptosis/drug effects , Blood Platelets/drug effects , Cell Survival/drug effects , DNA Copy Number Variations , Dose-Response Relationship, Drug , Fruit/chemistry , Humans , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/metabolism , Silybum marianum/chemistry , Plant Extracts/pharmacology , Reactive Oxygen Species/metabolism , Silybin , Silymarin/pharmacology
14.
Molecules ; 22(11)2017 Nov 10.
Article in English | MEDLINE | ID: mdl-29125572

ABSTRACT

Milk thistle (Silybum marianum) is a medicinal plant that has been used for thousands of years as a remedy for a variety of ailments. The main component of S. marianum fruit extract (silymarin) is a flavonolignan called silybin, which is not only the major silymarin element but is also the most active ingredient of this extract, which has been confirmed in various studies. This compound belongs to the flavonoid group known as flavonolignans. Silybin's structure consists in two main units. The first is based on a taxifolin, the second a phenyllpropanoid unit, which in this case is conyferil alcohol. These two units are linked together into one structure by an oxeran ring. Since the 1970s, silybin has been regarded in official medicine as a substance with hepatoprotective properties. There is a large body of research that demonstrates silybin's many other healthy properties, but there are still a lack of papers focused on its molecular structure, chemistry, metabolism, and novel form of administration. Therefore, the aim of this paper is a literature review presenting and systematizing our knowledge of the silybin molecule, with particular emphasis on its structure, chemistry, bioavailability, and metabolism.


Subject(s)
Silybum marianum/chemistry , Silymarin/chemistry , Silymarin/metabolism , Biological Availability , Silybin , Silymarin/administration & dosage , Silymarin/pharmacokinetics
15.
BMC Complement Altern Med ; 17(1): 396, 2017 Aug 10.
Article in English | MEDLINE | ID: mdl-28797264

ABSTRACT

BACKGROUND: Arachidonic acid metabolism by cyclooxygenase (COX) is a major pathway for blood platelets' activation, which is associated with pro-thrombotic platelet activity and the production of pro-inflammatory mediators. Inhibition of COX activity is one of the major means of anti-platelet pharmacotherapy preventing arterial thrombosis and reducing the incidence of cardiovascular events. Recent studies have presented that a silymarin (standardized extract of Milk thistle (Silybum marianum)) can inhibit the COX pathway. Accordingly, the aim of our study was to determine the effects of three major flavonolignans (silybin, silychristin and silydianin) on COX pathway activity in blood platelets. METHODS: We determined the effect of flavonolignans on arachidonic acid induced blood platelet aggregation, COX pathway metabolites formation, as well as COX activity in platelets. Additionally, we analysed the potential mechanism of this interaction using the bioinformatic ligand docking method. RESULTS: We observed that tested compounds decrease the platelet aggregation level, both thromboxane A2 and malondialdehyde formation, as well as inhibit the COX activity. The strongest effect was observed for silychristin and silybin. In our in silico study we showed that silychristin and silybin have conformations which interact with the active COX site as competitive inhibitors, blocking the possibility of substrate binding. CONCLUSIONS: The results obtained from this study clearly present the potential of flavonolignans as novel antiplatelet and anti-inflammatory agents.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Arachidonic Acid/blood , Blood Platelets/drug effects , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation/drug effects , Silybum marianum/chemistry , Silymarin/pharmacology , Binding, Competitive , Blood Platelets/metabolism , Flavonolignans/pharmacology , Humans , Inflammation Mediators/blood , Malondialdehyde/blood , Molecular Docking Simulation , Plant Extracts/pharmacology , Prostaglandin-Endoperoxide Synthases/blood , Silybin , Silymarin/chemistry , Thromboxane A2/biosynthesis
16.
Bioelectromagnetics ; 38(5): 386-396, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28430370

ABSTRACT

As a result of ischaemia/reperfusion, massive generation of reactive oxygen species occurs, followed by decreased activity of antioxidant enzymes. Extremely low frequency electromagnetic fields (ELF-EMF) can modulate oxidative stress, but there are no clinical antioxidant studies in brain stroke patients. The aim of our study was to investigate the effect of ELF-EMF on clinical and antioxidant status in post-stroke patients. Fifty-seven patients were divided into two groups: ELF-EMF and non-ELF-EMF. Both groups underwent the same 4-week rehabilitation program. Additionally, the ELF-EMF group was exposed to an ELF-EMF field of 40 Hz, 7 mT for 15 min/day for 4 weeks (5 days a week). The activity of catalase and superoxide dismutase was measured in hemolysates, and total antioxidant status (TAS) determined in plasma. Functional status was assessed before and after the series of treatments using Activities of Daily Living (ADL), Mini-Mental State Examination (MMSE), and Geriatric Depression Scale (GDS). Applied ELF-EMF significantly increased enzymatic antioxidant activity; however, TAS levels did not change in either group. Results show that ELF-EMF induced a significant improvement in functional (ADL) and mental (MMSE, GDS) status. Clinical parameters had positive correlation with the level of enzymatic antioxidant protection. Bioelectromagnetics. 38:386-396, 2017. © 2017 Wiley Periodicals, Inc.


Subject(s)
Brain Ischemia/complications , Oxidative Stress/radiation effects , Reactive Oxygen Species/metabolism , Recovery of Function/radiation effects , Stroke/physiopathology , Stroke/psychology , Aged , Catalase/metabolism , Depression/complications , Depression/therapy , Female , Humans , Magnetic Field Therapy , Male , Stroke/complications , Stroke/therapy , Superoxide Dismutase/metabolism
17.
Pol Merkur Lekarski ; 42(247): 34-37, 2017 Jan 23.
Article in Polish | MEDLINE | ID: mdl-28134230

ABSTRACT

Flavonolignans are the major bioactive components presented in the Milk thistle (Silybum marianum) standarized extract - silymarin. S. marianum is a medicinal plant, which has been using for thousands of years as a remedy for a variety of ailments. Since the 70s of the last century flavonolignans presented in silymarin have been regarded to the official medicine as substances having an hepatoprotective properties. Structurally, flavonolignans are composed of a flavonoid unit (taxifolin) and a phenylpropane unit (coniferyl alcohol), linked together by an oxeran ring. Many studies which have been conducted in recent years demonstrated that flavonolignans posses a various healthy properties. Flavonolignans modulate of a variety cell-signaling pathways as well as inhibit arachidonic acid metabolism, resulting in the reduction of pro-inflammatory mediators formation. The researches performed in last year's demonstrated that the major flavonolignan - silybin is able to inhibit two blood coagulation factors: thrombin and FXa. Flavonolignans have been also studied as a potential anticancer agents. This review article presents flavonolignans health benefits effects not only for the liver.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Anticoagulants/therapeutic use , Antineoplastic Agents/therapeutic use , Flavonolignans/therapeutic use , Anti-Inflammatory Agents/pharmacology , Anticoagulants/pharmacology , Antineoplastic Agents/pharmacology , Flavonolignans/pharmacology , Humans , Silybum marianum/chemistry , Plant Extracts/chemistry , Plants, Medicinal/chemistry , Signal Transduction/drug effects
18.
Chem Biol Interact ; 257: 35-45, 2016 Sep 25.
Article in English | MEDLINE | ID: mdl-27475864

ABSTRACT

Blood coagulation is a physiological process whose main task is prevention of blood loss from injured vessels. This process consists of a series of zymogens proteolytic activation leading to the generation of the main coagulation enzyme - thrombin. Besides its important role in blood coagulation process, thrombin is involved in many cardiovascular diseases, which are responsible for almost half of fatalities in economically developed countries. The evidence for the increased generation and in vivo activity of thrombin was observed in the plasma of individuals at high risk for clinically significant venous and arterial thromboembolic complications. Antioxidants activity of plants extracts has been well known for many years and was confirmed by many publications. However, during the last decade many research centers presented results suggesting anticoagulant potential of various plant extracts. Many researchers have also provided evidence that polyphenol compounds are able to inhibit the activity of many enzymes, including serine proteases. All research described in this review clearly indicate that polyphenols and polyphenol-rich extracts possess not only antioxidative but also anticoagulant properties and may be useful in creation of new therapeutic agents or dietary supplements. Based on described properties polyphenols would be very helpful with both prevention and treatment of thromboembolic complications associated with multiple failures of haemostasis, because the available therapeutic agents do not offer such double-effects (antioxidant and anticoagulant).


Subject(s)
Anticoagulants/pharmacology , Antioxidants/therapeutic use , Antioxidants/pharmacology , Hemostasis/drug effects , Humans , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Polyphenols/pharmacology , Polyphenols/therapeutic use
19.
Int J Biol Macromol ; 80: 702-9, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26208857

ABSTRACT

LPS is a Gram-negative bacteria endotoxin, which is an important pro-inflammatory agent. Blood platelets take part both in inflammatory processes and in pathogenesis of septic shock following accumulation of LPS. As a platelet agonist LPS causes the intraplatelet overproduction of ROS/RNS that are responsible for adverse modifications in the structure of platelet compounds being associated with a development of platelet-dependent diseases. Existing evidence suggests that anthocyanins (ATH) are able to protect the circulatory system. The antioxidative properties of ATH are believed to be mainly responsible for their positive health effects. The main goal of the present in vitro study was to investigate the potential protective properties of red cabbage ATH against oxidative damage induced by LPS in blood platelets. Exposure of platelets to LPS resulted in carbonyl group increase, 3-nitrotyrosine formation, lipid peroxidation and O2(•-) generation. We have shown that ATH extract effectively decreased oxidative stress induced by LPSs. The in silico analysis demonstrated that both cyanin and LPS were located at the same region of human TLR4-MD-2 complex. Our findings suggest that there could be two-way ATH platelet protection mechanism, by their antioxidant properties and directly by binding with TLRs.


Subject(s)
Anthocyanins/pharmacology , Antioxidants/pharmacology , Blood Platelets/drug effects , Blood Platelets/metabolism , Brassica/chemistry , Lipopolysaccharides/pharmacology , Oxidative Stress/drug effects , Adult , Anthocyanins/chemistry , Humans , Models, Molecular , Molecular Docking Simulation , Plant Extracts/chemistry , Plant Extracts/pharmacology , Protein Binding , Protein Conformation , Toll-Like Receptor 4/chemistry , Toll-Like Receptor 4/metabolism , Young Adult
20.
Int J Biol Macromol ; 72: 1152-8, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25285848

ABSTRACT

Matricaria chamomilla L. (MC), a member of the Asteraceae family, is one of the oldest medicinal plants, widely used worldwide for a variety of healing applications. Its recommendations, derived from both traditional and modern medicine, include numerous disorders such as inflammation, ulcers, wounds, gastrointestinal disorders, stomach ache, pharyngitis, rheumatic pain, as well as the other ailments. This work is focused on another aspect of the biological activity of chamomile polyphenolic-polysaccharide conjugates--their antioxidant properties in the protection of blood plasma components against in vitro oxidative stress. Measurements of DPPH and ABTS radical scavenging indicated considerable anti-free radical action of MC. Pre-incubation of blood plasma with MC considerably diminished the extent of ONOO(-)-induced oxidative modifications such as protein carbonyl groups, SH groups, 3-nitrotyrosine, as well as the formation of lipid hydroperoxides. The analysis of the FRAP assay result shows a considerable increase of ferric reducing ability of blood plasma in the presence of MC. The results obtained in this study indicate that polyphenolic-polysaccharide conjugates isolated from M. chamomilla substances possess antioxidant properties. The M. chamomilla macromolecular glycoconjugates may be useful in the creation of new natural-based medications or dietary supplements, helpful in the prevention and treatment of oxidative stress-mediated disorders.


Subject(s)
Antioxidants/pharmacology , Free Radical Scavengers/pharmacology , Matricaria/chemistry , Polyphenols/pharmacology , Polysaccharides/pharmacology , Benzothiazoles/chemistry , Biphenyl Compounds/chemistry , Humans , Lipid Peroxidation/drug effects , Picrates/chemistry , Protective Agents/pharmacology , Sulfonic Acids/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL